Obesity in Middle Age and Future Risk of Dementia: a 27 Year Longitudinal Population Based Study

Overview

Journal BMJ

Specialty General Medicine

Date 2005 May 3

PMID 15863436

Citations 436

Authors

Rachel A Whitmer

Erica P Gunderson

Elizabeth Barrett-Connor

Charles P Quesenberry Jr

Kristine Yaffe

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life.

Design: Analysis of prospective data from a multiethnic population based cohort.

Setting: Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation.

Participants: 10,276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994.

Main Outcome Measures: Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease.

Results: Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index > or = 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95% confidence interval 1.34 to 2.26), while overweight people (body mass index 25.0-29.9) had a 35% greater risk of dementia (1.35, 1.14 to 1.60) compared with those of normal weight (body mass index 18.6-24.9). Compared with those in the lowest fifth, men and women in the highest fifth of the distribution of subscapular or tricep skinfold thickness had a 72% and 59% greater risk of dementia, respectively (1.72, 1.36 to 2.18, and 1.59, 1.24 to 2.04).

Conclusions: Obesity in middle age increases the risk of future dementia independently of comorbid conditions.

Citing Articles

Is late-life vulnerability to cardiovascular disease risk associated with longitudinal tau accumulation in older adults with mild cognitive impairment?.

Dratva M, Diaz J, Thomas M, Shen Q, Tsiknia A, Rostowsky K JAR Life. 2025; 14:100001.

PMID: 40046641 PMC: 11879684. DOI: 10.1016/j.jarlif.2025.100001.

Nitrogen dioxide exposure attenuates or even reverses the association between physical activity and fasting plasma glucose levels in non-diabetic elderly Chinese adults.

Zhang C, Wu Q, Cheng X, Tian Z, Li J, Liu Q BMC Public Health. 2025; 25(1):872.

PMID: 40045267 PMC: 11881241. DOI: 10.1186/s12889-025-22050-6.

Neuropsychiatric Abnormalities in Metabolic Disturbances: Interplay of Adipokines and Neurotransmission.

Cheon S, Song J Mol Neurobiol. 2025; .

PMID: 40042730 DOI: 10.1007/s12035-025-04797-6.

What Is the Impact of Obesity-Related Comorbidities on the Risk of Premature Aging in Patients with Severe Obesity?: A Cross-Sectional Study.

Dudek A, Zapala B, Gorostowicz A, Kawa I, Ciszek K, Tylec P Medicina (Kaunas). 2025; 61(2).

PMID: 40005412 PMC: 11857414. DOI: 10.3390/medicina61020293.

Quantifying Cognitive Function in Diabetes: Relationships Between AD8 Scores, HbA1c Levels, and Other Diabetic Comorbidities.

Chao H, Lin M, Fang T, Hsu M, Liang C, Lee M Biomedicines. 2025; 13(2).

PMID: 40002752 PMC: 11853454. DOI: 10.3390/biomedicines13020340.

References

Baumgartner R, Heymsfield S, Roche A . Human body composition and the epidemiology of chronic disease. Obes Res. 1995; 3(1):73-95. DOI: 10.1002/j.1550-8528.1995.tb00124.x. View

Collen M, Davis L . The multitest laboratory in health care. J Occup Med. 1969; 11(7):355-60. View

Yaffe K, Blackwell T, Kanaya A, Davidowitz N, Barrett-Connor E, Krueger K . Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004; 63(4):658-63. DOI: 10.1212/01.wnl.0000134666.64593.ba. View

Lofgren I, Herron K, Zern T, West K, Patalay M, Shachter N . Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. J Nutr. 2004; 134(5):1071-6. DOI: 10.1093/jn/134.5.1071. View

Bray G . Obesity is a chronic, relapsing neurochemical disease. Int J Obes Relat Metab Disord. 2003; 28(1):34-8. DOI: 10.1038/sj.ijo.0802479. View

Ramos E, Xu Y, Romanova I, Middleton F, Chen C, Quinn R . Is obesity an inflammatory disease?. Surgery. 2003; 134(2):329-35. DOI: 10.1067/msy.2003.267. View

Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I . An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003; 163(13):1524-8. DOI: 10.1001/archinte.163.13.1524. View

Karter A, Mayer-Davis E, Selby J, DAgostino Jr R, Haffner S, Sholinsky P . Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes. 1996; 45(11):1547-55. DOI: 10.2337/diab.45.11.1547. View

Beckett L, Scherr P, Field T, Chown M, Pilgrim D, Bennett D . Weight loss in people with Alzheimer's disease: a prospective population based analysis. BMJ. 1997; 314(7075):178-9. PMC: 2125711. DOI: 10.1136/bmj.314.7075.178. View

10.

Knittweis J . Weight loss precedes Alzheimer's disease symptoms: a case study. J Am Geriatr Soc. 1998; 46(4):540-1. DOI: 10.1111/j.1532-5415.1998.tb02487.x. View

11.

Kalmijn S, Curb J, Rodriguez B, Yano K, Abbott R . The association of body weight and anthropometry with mortality in elderly men: the Honolulu Heart Program. Int J Obes Relat Metab Disord. 1999; 23(4):395-402. DOI: 10.1038/sj.ijo.0800832. View

12.

. RECOMMENDATIONS concerning body measurements for the characterization of nutritional status. Hum Biol. 1956; 28(2):111-23. View

13.

Yaffe K, Kanaya A, Lindquist K, Simonsick E, Harris T, Shorr R . The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004; 292(18):2237-42. DOI: 10.1001/jama.292.18.2237. View

14.

Gustafson D, Steen B, Skoog I . Body mass index and white matter lesions in elderly women. An 18-year longitudinal study. Int Psychogeriatr. 2004; 16(3):327-36. DOI: 10.1017/s1041610204000353. View

15.

Gustafson D, Lissner L, Bengtsson C, Bjorkelund C, Skoog I . A 24-year follow-up of body mass index and cerebral atrophy. Neurology. 2004; 63(10):1876-81. DOI: 10.1212/01.wnl.0000141850.47773.5f. View

16.

Whitmer R, Sidney S, SELBY J, Johnston S, Yaffe K . Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 64(2):277-81. DOI: 10.1212/01.WNL.0000149519.47454.F2. View

17.

Landin K, Stigendal L, Eriksson E, Krotkiewski M, Risberg B, Tengborn L . Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism. 1990; 39(10):1044-8. DOI: 10.1016/0026-0495(90)90164-8. View

18.

Krieger N . Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992; 82(5):703-10. PMC: 1694121. DOI: 10.2105/ajph.82.5.703. View

19.

Selby J, Friedman G, Quesenberry Jr C . Precursors of essential hypertension. The role of body fat distribution pattern. Am J Epidemiol. 1989; 129(1):43-53. DOI: 10.1093/oxfordjournals.aje.a115123. View

20.

Arellano M, Petersen G, Petitti D, Smith R . The California Automated Mortality Linkage System (CAMLIS). Am J Public Health. 1984; 74(12):1324-30. PMC: 1652697. DOI: 10.2105/ajph.74.12.1324. View